The monoclonal antibodies nivolumab and ipilimumab have already undergone several early benefit assessments in various oncological indications. Since April 2021, the drug combination has also been approved for first-line ...
Oct 4, 2021
0
0
Findings from a national study by researchers at Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and external collaborators suggest that sex and age are crucial factors in the care and survival ...
Sep 22, 2021
0
42
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new ...
Sep 20, 2021
0
143
Cancer cells proliferate despite a myriad of stresses—from oxygen deprivation to chemotherapy—that would kill any ordinary cell. Now, researchers at UC San Francisco have gained insight into how they may be doing this ...
Sep 20, 2021
0
83
The experience of a fruit fly dying from cancer may seem worlds away from that of a human with a life-threatening tumor, yet University of California Berkeley researchers are finding commonalities between the two that could ...
Sep 16, 2021
0
31
Hundreds of cancer-linked genes play a different role in causing disease than scientists had expected.
Sep 16, 2021
0
51
A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival ...
Sep 12, 2021
0
4
Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers ...
Sep 9, 2021
0
73
An artificial intelligence (AI) program can spot signs of lung cancer on CT scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International ...
Sep 8, 2021
0
5
The latest special issue of PLOS Medicine features five studies outlining novel strategies for detecting cancer and for identifying minimal residual disease—when a small amount of tumor cells survive treatment, potentially ...
Aug 31, 2021
0
11
